On 16/5/2023, a unique international conference will be held on Oculopharyngeal muscular dystrophy (OPMD) and related disorders, the purpose of which is to promote applied research for the development of treatments for the disease. During the conference there will also be a special session for patients and their families under the title “The light at […]
On 16/5/2023, a unique international conference will be held on OPMD and related disorders, the purpose of which is to promote applied research for the development of treatments for the disease. During the conference there will also be a special session for patients and their families under the title “The light at the end of
Development of a genetic treatment for OPMD disease Benitec Biopharma Inc. – a US biotechnology company focused on the development of novel genetic drugs. Its patented platform, called DNA-directed RNA interference, or ddRNAi, combines RNA interference with gene therapy to create drugs that promote sustained suppression of disease-causing genes after a single administration. The Company
Development of a genetic treatment for OPMD disease Read More »
The scope of activities for the achievement of the association’s goals has greatly expanded and is in need for additional volunteer activists. You can significantly improve the quality of life of patients with OPMD if you volunteer to help in one of the many tasks that derive from the multi-system involvement of OPMD. Eligible volunteers
